Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ELN | P15502 | Elastin (Tropoelastin) | Disease related genesHuman disease related genesPlasma proteins | Williams-Beuren syndrome | Fusion and delivery mediation | 1 | 0.53 | |||
| EPB41 | P11171 | Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1) | Disease related genesHuman disease related genesPlasma proteins | ElliptocytosisHereditary hemolytic anemiaPyropoikilocytosis | Fusion and delivery mediation | 1 | 0.53 | |||
| EPHA2 | P29317 | Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) | 1 | Brain cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | |||
| EPHA3 | P29320 | Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) | Cancer-related genesDisease related genesEnzymes | 1 | Acute myeloid leukaemiaBrain cancerMalignant haematopoietic neoplasm | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| EPOR | P19235 | Erythropoietin receptor (EPO-R) | 1 | AnemiaDepressionGeneral pain disorder | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.53 | |||
| EXOC7 | Q9UPT5 | Exocyst complex component 7 (Exocyst complex component Exo70) | Disease related genesHuman disease related genesPotential drug targets | Epilepsy | Fusion and delivery mediationMetabolism mediation | 1 | 0.53 | |||
| FCAR | P24071 | Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Diabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FCG2A | P12318 | Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32) | CD markersFDA approved drug targetsHuman disease related genes | 1 | Chronic kidney diseaseLupus erythematosusThrombocytopenia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 | ||
| FCG2B | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32) | Cancer-related genesCD markersDisease related genes | 1 | Systemic lupus erythematosusAutoimmune diseaseB-cell lymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.53 | ||
| FCG3A | P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a) | CD markersDisease related genesFDA approved drug targets | 1 | Hodgkin lymphomaLymphomaMature T-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.53 |